22.90 USD
↘ 0.08 (0.34%)PRE MARKET (AS OF 05:50 AM EDT)
Open?$22.98
High?$22.98
Low?$22.90
Prev. Close?$22.98
Volume?3
Avg. Volume?319.3K
VWAP?$22.98
Rel. Volume?0.00x
Bid / Ask
Bid?$21.20 × 100
Ask?$24.60 × 100
Spread?$3.40
Midpoint?$22.90
Valuation & Ratios
Market Cap?806.5M
Shares Out?35.1M
Float?23.9M
Float %?75.0%
P/E Ratio?N/A
P/B Ratio?3.31
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
Themes
Employees
68
Market Cap
806.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-02-02
Address
650 CASTRO STREET, SUITE 450
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
MOUNTAIN VIEW, CA 94041
Phone: 773-255-5012
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?20.52Strong
Quick Ratio?20.52Strong
Cash Ratio?20.11Strong
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?3.31FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-7.3CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-30.5%WEAK▾
ROA?-26.9%WEAK▾
Cash Flow & Enterprise
FCF?$-62860000
Enterprise Value?$561.1M
Fundamentals ratios updated end of day